Gynecomastia refers to the proliferation of the glandular tissue in the male breast or the enlargement of the male breast. The major cause of gynecomastia is the hormonal imbalance which occurs between the estrogen level and androgen activity amongst the males. Several medications such as anti-androgens, anti-depressants, etc. are also associated with the cause of gynecomastia. Gynecomastia is common in infancy, puberty and middle-aged. The symptoms of gynecomastia include swelling, nipple discharge, pain, etc. Overuse of herbal products such as tea tree or lavender used in shampoo, soaps, and lotions are also associated with gynecomastia. Based on the product type, the Gynecomastia Treatment market has been segmented into drugs and surgeries. The medications used for the treatment of gynecomastia include tamoxifen, Raloxifene, Aromatase Inhibitors, and other medications.
This report contains market size and forecasts of Gynecomastia Treatment in Global, including the following market information:
Global Gynecomastia Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Gynecomastia Treatment market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Drugs Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Gynecomastia Treatment include Cadila Pharmaceuticals Ltd, Sun Pharmaceuticals Industries Ltd, Zydus Cadila Healthcare Ltd, Biochem Pharmaceutical Industries Ltd, Dr. Reddy's Laboratories Ltd, Micro Nova Pharmaceuticals Ltd and Kee Pharma Ltd, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Gynecomastia Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Gynecomastia Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Gynecomastia Treatment Market Segment Percentages, by Type, 2021 (%)
Drugs
Surgical Treatment
Global Gynecomastia Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Gynecomastia Treatment Market Segment Percentages, by Application, 2021 (%)
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Global Gynecomastia Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Gynecomastia Treatment Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Gynecomastia Treatment revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Gynecomastia Treatment revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Cadila Pharmaceuticals Ltd
Sun Pharmaceuticals Industries Ltd
Zydus Cadila Healthcare Ltd
Biochem Pharmaceutical Industries Ltd
Dr. Reddy's Laboratories Ltd
Micro Nova Pharmaceuticals Ltd
Kee Pharma Ltd